What Cerevel Therapeutics Holdings, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Burgess Paul D. | See Remarks | Aug 01 | Disposition to Issuer · D | −45,727 | — | — | 0 |
| Tregoning Kathleen | See Remarks | Aug 01 | Disposition to Issuer · D | −10,666 | — | — | 0 |
| Giordano Douglas E. | Director | Aug 01 | Disposition to Issuer · D | −10,461 | — | — | 0 |
| Giordano Douglas E. | Director | Aug 01 | Disposition to Issuer · D | −3,282 | — | — | 10,461 |
| Renaud Ronald C Jr | President & CEO | Aug 01 | Disposition to Issuer · D | −83,857 | — | — | 0 |
| Renaud Ronald C Jr | President & CEO | Aug 01 | Disposition to Issuer · D | −160,452 | — | — | 0 |
| Greene Gabrielle E | Director | Aug 01 | Disposition to Issuer · D | −10,461 | — | — | 0 |
| Greene Gabrielle E | Director | Aug 01 | Disposition to Issuer · D | −48,415 | — | — | 10,461 |
| Bain Capital Investors Llc | Director | Aug 01 | Disposition to Issuer · D | −65,679,781 | — | — | 0 |
| Sanchez Ramiro | Chief Medical Officer | Aug 01 | Disposition to Issuer · D | −14,673 | — | — | 0 |
| Koppel Adam | Director | Aug 01 | Disposition to Issuer · D | −65,679,781 | — | — | 0 |
| Koppel Adam | Director | Aug 01 | Disposition to Issuer · D | −10,461 | — | — | 0 |
| Koppel Adam | Director | Aug 01 | Disposition to Issuer · D | −3,282 | — | — | 10,461 |
| Akamine Scott | Chief Legal Officer | Aug 01 | Disposition to Issuer · D | −7,527 | — | — | 0 |
| Riedel Norbert G | Director | Aug 01 | Disposition to Issuer · D | −10,461 | — | — | 0 |
| Riedel Norbert G | Director | Aug 01 | Disposition to Issuer · D | −46,092 | — | — | 10,461 |
| Patrick Deval L | Director | Aug 01 | Disposition to Issuer · D | −10,461 | — | — | 0 |
| Patrick Deval L | Director | Aug 01 | Disposition to Issuer · D | −3,282 | — | — | 10,461 |
| Pfizer Inc | Insider | Aug 01 | Tender Offer · U | −27,349,211 | $45.00 | −$1.23B | 0 |
| Coles N Anthony | Director | Aug 01 | Disposition to Issuer · D | −10,290 | — | — | 0 |
Loading...